Global Expansion Pulse: Poly Medicure Acquires Medistream SA In EUR 31 Million Deal

Poly Medicure Ltd has announced the acquisition of a 100 percent stake in Medistream SA, a European medical device company, at an enterprise value of EUR 31 million. The strategic move, disclosed on September 24, 2025, marks a significant step in Poly Medicure’s international growth strategy and strengthens its presence in the European healthcare market.

 

Key highlights from the acquisition:

 

- Poly Medicure acquires full ownership of Medistream SA for EUR 31 million  

- Medistream SA specializes in infusion therapy and critical care devices  

- The acquisition includes manufacturing assets, distribution networks, and IP portfolio  

- Deal structured through a cash and debt mix, with integration expected by Q1 FY26  

- Medistream’s operations span Switzerland, Germany, and select Eastern European markets  

 

Strategic Rationale And Synergies

 

The acquisition is expected to enhance Poly Medicure’s product offerings, expand its customer base, and accelerate regulatory approvals across Europe. Key synergies include:

 

- Access to CE-certified product lines and established hospital relationships  

- Integration of R&D capabilities for next-gen infusion systems  

- Expansion of Poly Medicure’s export footprint and revenue diversification  

- Operational efficiencies through shared sourcing and logistics  

 

The transaction aligns with Poly Medicure’s long-term goal of becoming a global leader in medical disposables and devices.

 

Sources: BSE Corporate Filings, Economic Times Healthcare Desk, BusinessLine Medical Devices Tracker.